PFBT
IMNM icon

Parkside Financial Bank & Trust’s Immunome IMNM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59K Hold
75
– – ﹤0.01% 2256
2026
Q1 		$1.64K Hold
75
– – ﹤0.01% 2189
2025
Q4 		$1.61K Hold
75
– – ﹤0.01% 2175
2025
Q3 		$879 Hold
75
– – ﹤0.01% 2338
2025
Q2 		$698 Buy
+75
New +$615 ﹤0.01% 2384

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Parkside Financial Bank & Trust's IMNM Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Immunome (IMNM) position steady in Q2 2026 at 75 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Parkside Financial Bank & Trust first reported a position in IMNM in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.64K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Parkside Financial Bank & Trust held 75 shares of Immunome worth $1.59K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2256 holding.
  • Parkside Financial Bank & Trust first reported a position in Immunome in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Immunome position peaked at $1.64K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.